# A Clinical Trial of TQC3927 Powder for Inhalation in Chronic Obstructive Pulmonary Disease

> **NCT06711991** · PHASE1 · COMPLETED · sponsor: **Chia Tai Tianqing Pharmaceutical Group Co., Ltd.** · enrollment: 48 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** TQC3927 powder for inhalation
- **DRUG:** TQC3927 powder for inhalation placebo

## Key facts

- **NCT ID:** NCT06711991
- **Lead sponsor:** Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-11
- **Primary completion:** 2025-08-11
- **Final completion:** 2025-08-11
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06711991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06711991, "A Clinical Trial of TQC3927 Powder for Inhalation in Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06711991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*